UBE2V2 anticorps (AbBy Fluor® 350)

N° du produit ABIN1402365

Détail du produit anti-UBE2V2 anticorps (AbBy Fluor® 350)

Antigène: UBE2V2 (Ubiquitin-Conjugating Enzyme E2 Variant 2 (UBE2V2))

Reactivité: Humain, Souris, Rat

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp UBE2V2 est conjugé à/à la AbBy Fluor® 350

Application: Western Blotting (WB), Immunofluorescence (Paraffin-embedded Sections) (IF (p))

Réactivité croisée: Humain, Souris, Rat

Purification: Purified by Protein A.

Immunogène: KLH conjugated synthetic peptide derived from human MMS2/EDPF1

Isotype: IgG

Information d'application

Indications d'application: IF(IHC-P) 1:50-200

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

Date de péremption: 12 months

Détails sur UBE2V2

Antigène: UBE2V2 (Ubiquitin-Conjugating Enzyme E2 Variant 2 (UBE2V2))

Autre désignation: EDPF1 (UBE2V2 Produits)

Synonymes: anticorps DDVIT1, anticorps DDVit-1, anticorps EDAF-1, anticorps EDPF-1, anticorps EDPF1, anticorps MMS2, anticorps UEV-2, anticorps UEV2, anticorps mms2, anticorps uev2, anticorps edpf1, anticorps uev-2, anticorps ddvit1, anticorps edaf-1, anticorps edpf-1, anticorps ddvit-1, anticorps 1110021H13Rik, anticorps 4632410D19Rik, anticorps 5730524P06Rik, anticorps 6820402M05, anticorps AI848315, anticorps C81524, anticorps wu:fb18b11, anticorps wu:fb24d11, anticorps zgc:63717, anticorps UBE2V2, anticorps TMEM189-UBE2V1, anticorps ubiquitin conjugating enzyme E2 V2, anticorps ubiquitin-conjugating enzyme E2 variant 2, anticorps ubiquitin conjugating enzyme E2 V2 S homeolog, anticorps Ubiquitin-conjugating enzyme E2 variant 2, anticorps UBE2V2, anticorps Ube2v2, anticorps ube2v2, anticorps ube2v2.S, anticorps PTRG_00824, anticorps ub2v2, anticorps Tsp_08004

Sujet:

Synonyms: 1 alpha 25 dihydroxyvitamin D3 inducible, DDVit 1, DDVIT1, EDAF-1, EDAF1, EDPF-1, EDPF1, Enterocyte dferentiation associated factor EDAF 1, Enterocyte dferentiation promoting factor, Enterocyte dferentiation-associated factor 1, Enterocyte dferentiation-promoting factor 1, Methyl methanesulfonate sensitive 2, MMS 2, MMS2, MMS2 homolog, UB2V2_HUMAN, UBE2V 2, UBE2V2, Ubiquitin conjugating enzyme E2 variant 2, Ubiquitin conjugating enzyme E2v2, Ubiquitin-conjugating enzyme E2 variant 2, UEV 2, UEV2, Vitamin D3 inducible protein, Vitamin D3-inducible protein.

Background: Has no ubiquitin ligase activity on its own. The UBE2V2/UBE2N heterodimer catalyzes the synthesis of non-canonical poly-ubiquitin chains that are linked through 'Lys-63'. This type of poly-ubiquitination does not lead to protein degradation by the proteasome. Mediates transcriptional activation of target genes. Plays a role in the control of progress through the cell cycle and differentiation. Plays a role in the error-free DNA repair pathway and contributes to the survival of cells after DNA damage.

ID gène: 7336

Pathways: Positive Regulation of Response to DNA Damage Stimulus